Insights & Opinions

Insights, opinions and commentaries from experts in the biobanking field. Contribute an Article

As Collaboration for Biobanking and Clinical Trials Grows, Software Systems Rise to the Challenge.

Sponsored content brought to you by  New developments in medical IT systems are helping link clinical data with biospecimens, creating new potential for biobanks and clinical research. Because biospecimens are only as valuable as the data associated with them, it...

Interview with Jill Mullan, Chief Operating Officer at iSpecimen

Every medical breakthrough starts with the study of afflicted patients, often through their blood, tumor tissue, or other biological material. Thus, it’s critical for the advancement of life science research that scientists can easily procure the human biospecimens they...
Meet ISO 20387 Requirements with a Laboratory Software for Biobanking

ISO 20387:2018: The Key to Quality Biobanking

In the last two decades, clinical research has grown exponentially; therefore, the demand for high-quality biological samples has increased, not to mention the last two years. The most recent pandemic has accelerated the need to optimize and automate processes...
Artificial Intelligence: The New Age of Biobanking

Artificial Intelligence: The New Age of Biobanking and Medical Research

Artificial intelligence (AI) is slowly but surely transforming the practice of medicine. Advancements in digital data collection, computing infrastructure, and machine learning have allowed artificial intelligence applications to spread into previously untapped domains. Today, the revolution in biobanks, biorepositories,...
Digitization: Enabling Biobanks Navigate Through Regulatory Challenges

Digitization: Enabling Biobanks Navigate Through Regulatory Challenges

Over the past two decades, there has been an increased need for collecting, curating, storing, and distributing biological specimens to gain specific information into the genetic makeup of diseases . This has sparked the demand for biobanking. Genetic and biomedical...
Challenges in biobanking: Underutilization of Samples

Challenges in Biobanking: Underutilization of Samples

When it comes to predictions, I agree with Nobel Prize winner Niels Bohr: "Prediction is very difficult, especially if it's about the future”. Nevertheless, I dare to predict that there will be some consolidation in biobanks in the next...

The Anatomy of a Refrigeration Failure: What Happens at 2:00 a.m. When Mission Critical...

Article contributed by Chris Wilkes, chief commercial officer at KLATU Networks, Inc. Ultralow temperature (ULT) freezers often contain high-value biopharmaceuticals and/or irreplaceable research. When you leave at the end of the day or for the weekend, you need confidence that...

New Trends in Biobanking Based on Main International Events in 2019

What were the most attractive biobanking ideas in 2019? ISBER (International Society for Biological and Environmental Repositories) and ESBB (European, Middle Easter and African Society for Biopreservation and Biobanking) are the two biggest world leaders in the biobanking area. Every...

How Biobanks Can Support Personalized Medicine

Biobanks should be an integral part of a comprehensive research platform, not exclusively viewed as a service provider or freezer farm managed with excel sheets. For biobanks to be be viewed as a contributing partner and one that can...

Interview with Dr. Robert Hewitt, Biosample Hub

The pharmaceutical industry has the infrastructural and financial resources to bring novel drugs and vaccines into the clinic. It would greatly help expedite their timeline if they had access to biobanks at academic institutes, in order to better understand...

⭐ Recently Featured

🔥 Popular Posts

X